Literature DB >> 15818650

Two major spondylarthropathy phenotypes are distinguished by pattern analysis in multiplex families.

Raphaël Porcher1, Roula Said-Nahal, Maria-Antonietta D'Agostino, Corinne Miceli-Richard, Maxime Dougados, Maxime Breban.   

Abstract

OBJECTIVE: To examine whether spondylarthropathy (SpA) disease manifestations would combine in any ordered pattern among patients from SpA multiplex families.
METHODS: SpA patients (n = 540) belonging to 190 multiplex families were thoroughly investigated. Clinical data was collected, systematic pelvic radiographs were taken, and HLA-B27 status was determined. The patterns of SpA manifestations were examined by several methods, including multiple correspondence analysis, nonhierarchical and hierarchical clustering, and discriminant analysis.
RESULTS: The nonhierarchical cluster analysis allowed us to classify patients, independent of disease duration, into 2 major groups of comparable size. Group A contained a majority of the women, whereas group B predominantly consisted of men. The 2 groups were very similar regarding axial symptoms, radiographic sacroiliitis, and uveitis. Group B was characterized by a younger age at onset and a higher frequency of clinical enthesitis, peripheral arthritis, dactylitis, psoriasis, and inflammatory bowel disease than group A. Patients belonging to those groups exhibited some degree of familial aggregation, thereby supporting their intrinsic validity.
CONCLUSION: Pattern analysis of SpA manifestations among familial SpA allowed us to recognize 2 main clusters independent of disease duration. Furthermore, there was a trend toward aggregation by cluster among families, suggesting that they are determined by specific genetic factors. These clusters may indeed correspond to different severity patterns.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15818650     DOI: 10.1002/art.21070

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  7 in total

Review 1.  Revisiting MHC genes in spondyloarthritis.

Authors:  Maxime Breban; Félicie Costantino; Claudine André; Gilles Chiocchia; Henri-Jean Garchon
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

2.  Clinical features of ankylosing spondylitis may correlate with HLA-B27 polymorphism.

Authors:  Zhen Wu; Zhiming Lin; Qiujing Wei; Jieruo Gu
Journal:  Rheumatol Int       Date:  2008-10-25       Impact factor: 2.631

3.  Common genetic determinants of uveitis shared with other autoimmune disorders.

Authors:  Mary J Mattapallil; Azize Sahin; Phyllis B Silver; Shu-Hui Sun; Chi-Chao Chan; Elaine F Remmers; J Fielding Hejtmancik; Rachel R Caspi
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

4.  Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up.

Authors:  Isabelle Desguerre; Christo Christov; Michele Mayer; Reinhard Zeller; Henri-Marc Becane; Sylvie Bastuji-Garin; France Leturcq; Catherine Chiron; Jamel Chelly; Romain K Gherardi
Journal:  PLoS One       Date:  2009-02-05       Impact factor: 3.240

Review 5.  Undifferentiated spondyloarthritis: a global perspective.

Authors:  Rubén Burgos-Vargas
Journal:  Curr Rheumatol Rep       Date:  2007-10       Impact factor: 4.592

6.  A cluster analysis of patients with axial spondyloarthritis using tumour necrosis factor alpha inhibitors based on clinical characteristics.

Authors:  Seulkee Lee; Seonyoung Kang; Yeonghee Eun; Hong-Hee Won; Hyungjin Kim; Hoon-Suk Cha; Eun-Mi Koh; Jaejoon Lee
Journal:  Arthritis Res Ther       Date:  2021-11-15       Impact factor: 5.156

7.  Patterns of comorbidity and disease characteristics among patients with ankylosing spondylitis-a cross-sectional study.

Authors:  Lotta Ljung; Björn Sundström; Johan Smeds; Maria Ketonen; Helena Forsblad-d'Elia
Journal:  Clin Rheumatol       Date:  2017-11-08       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.